11 December 2023

Recall of 2 Lots of Pharmaceutical Product Crysvita (Burosumab)

Reference: CIR-2023-00000217

To all Health, facilities / all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the Circular issued by the MOHAP for perusal and adhere to what is stated

 

Recall of 2 Lots of Pharmaceutical Product Crysvita (Burosumab)

 

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Crysvita (Burosumab).pdf:

View Document